Nanobiotix S.A.
NANO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | -€0 | €0 | €0 | €0 |
| % Growth | -138.6% | 529.4% | 47,660% | – |
| Cost of Goods Sold | €0 | €0 | €0 | -€0 |
| Gross Profit | -€0 | €0 | €0 | €0 |
| % Margin | 100% | 100% | 68.6% | 26,470% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€0 | -€0 | €0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | 589.1% | -89.1% | -1,057.2% | -525,790% |
| Other Income/Exp. Net | €0 | -€0 | -€0 | €0 |
| Pre-Tax Income | -€0 | -€0 | -€0 | -€0 |
| Tax Expense | €0 | €0 | -€0 | -€0 |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | 586.9% | -132.1% | -1,194.3% | -470,030% |
| EPS | -1.44 | -1.08 | -1.64 | -1.35 |
| % Growth | -33.3% | 34.1% | -21.5% | – |
| EPS Diluted | -1.44 | -1.08 | -1.64 | -1.35 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | 530.8% | -100.1% | -1,126.2% | -456,050% |